SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17381380
Source:
http://linkedlifedata.com/resource/pubmed/id/17381380
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001554
,
umls-concept:C0002871
,
umls-concept:C0010340
,
umls-concept:C0357126
,
umls-concept:C0937950
,
umls-concept:C1273870
,
umls-concept:C1707455
pubmed:issue
4
pubmed:dateCreated
2007-3-26
pubmed:abstractText
To compare the effectiveness of darbepoetin alfa with epoetin alfa (recombinant human erythropoietin [rHuEPO]) for achieving transfusion independence and increasing hemoglobin concentrations in critically ill patients.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8111305
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Erythropoietin
,
http://linkedlifedata.com/resource/pubmed/chemical/Hematinics
,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobins
,
http://linkedlifedata.com/resource/pubmed/chemical/Iron Compounds
,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/darbepoetin alfa
,
http://linkedlifedata.com/resource/pubmed/chemical/epoetin alfa
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0277-0008
pubmed:author
pubmed-author:BrophyGretchen MGM
,
pubmed-author:HarpeSpencer HSH
,
pubmed-author:VoilsStacy ASA
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
535-41
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17381380-Adult
,
pubmed-meshheading:17381380-Aged
,
pubmed-meshheading:17381380-Anemia
,
pubmed-meshheading:17381380-Blood Transfusion
,
pubmed-meshheading:17381380-Critical Illness
,
pubmed-meshheading:17381380-Drug Administration Schedule
,
pubmed-meshheading:17381380-Erythropoietin
,
pubmed-meshheading:17381380-Female
,
pubmed-meshheading:17381380-Hematinics
,
pubmed-meshheading:17381380-Hemoglobins
,
pubmed-meshheading:17381380-Humans
,
pubmed-meshheading:17381380-Intensive Care
,
pubmed-meshheading:17381380-Intensive Care Units
,
pubmed-meshheading:17381380-Iron Compounds
,
pubmed-meshheading:17381380-Male
,
pubmed-meshheading:17381380-Middle Aged
,
pubmed-meshheading:17381380-Recombinant Proteins
,
pubmed-meshheading:17381380-Retrospective Studies
,
pubmed-meshheading:17381380-Time Factors
,
pubmed-meshheading:17381380-Trauma Centers
,
pubmed-meshheading:17381380-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness.
pubmed:affiliation
School of Pharmacy, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, Virginia 23298-0533, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study